CBT

CBT Financing Cash Flow

-$234.00MTTM · USD

Period ending:

CBT FY Cash from FinancingUSD
CBT FY Cash from Financing1989-09-30: -$39.50M1990-09-30: $150.00M1991-09-30: $44.90M1992-09-30: -$39.30M1993-09-30: -$74.80M1994-09-30: -$31.30M1995-09-30: -$197.20M1996-09-30: $12.80M1997-09-30: -$15.20M1998-09-30: -$130.40M1999-09-30: -$69.00M2000-09-30: -$184.00M2001-09-30: -$176.00M2002-09-30: -$164.00M2003-09-30: -$64.00M2004-09-30: -$101.00M2005-09-30: -$81.00M2006-09-30: -$82.00M2007-09-30: -$211.00M2008-09-30: $23.00M2009-09-30: -$127.00M2010-09-30: -$57.00M2011-09-30: -$72.00M2012-09-30: $606.00M2013-09-30: -$206.00M2014-09-30: -$302.00M2015-09-30: -$256.00M2016-09-30: -$184.00M2017-09-30: -$125.00M2018-09-30: -$141.00M2019-09-30: -$234.00M2020-09-30: -$132.00M2021-09-30: -$60.00M2022-09-30: $145.00M2023-09-30: -$403.00M2024-09-30: -$415.00M2025-09-30: -$336.00M$606.00M-$415.00M
1989-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CBT financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Sep 30, 1989 to Sep 30, 2025.

Cabot Corp Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-336,000,000
-415,000,000
-403,000,000
145,000,000
-60,000,000
-132,000,000
-234,000,000
-141,000,000
-125,000,000
-184,000,000
-256,000,000
-302,000,000
-206,000,000
606,000,000
-72,000,000
-57,000,000
-127,000,000
23,000,000
-211,000,000
-82,000,000
-81,000,000
-101,000,000
-64,000,000
-164,000,000
-176,000,000
-184,000,000
-69,000,000
-130,400,000
-15,200,000
12,800,000
-197,200,000
-31,300,000
-74,800,000
-39,300,000
44,900,000
150,000,000
-39,500,000

Compare financing cash flow

All CBT financial metrics · CBT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.